Development
Clinical Development Phases
IND: Investigational New Drug NDA: New Drug Approval
Modiblast Plan
Completion Status
Preclinic
Preclinic
100%
Proof of Concept
Preclinic
10%
Drug Reformulation
Preclinic
0%